首页> 外国专利> Protein nanocages with enhanced mucus penetration for targeted tissue and intracellular delivery

Protein nanocages with enhanced mucus penetration for targeted tissue and intracellular delivery

机译:具有增强的粘液渗透的蛋白质纳米物体用于靶向组织和细胞内递送

摘要

A protein nanocage formulation with enhanced mucus penetration capability and colloidal stability provides controlled delivery of therapeutic, prophylactic, or diagnostic agents to tumors. A dense coating of a surface altering agent such as polyethylene glycol on self-assembled protein nanocages enhances the rapid and uniform distribution of the formulation at mucosal tissues following topical administration, enhances circulation time following intravenous administration, and enhances penetration into hypoxic tumor cores. The density and the molecular weight of surface altering agents are selected to allow the protein nanocages to also bind to tumor cell receptors and release chemotherapeutic agents after tumor cell uptake. Agents delivered in the formulation have better efficacy compared to carrier-free agents. A method of making the protein nanocage formulation with enhanced mucus penetration and colloidal stability is also provided.
机译:具有增强的粘液渗透能力和胶体稳定性的蛋白质纳米型制剂可提供治疗,预防性或诊断剂的控制递送至肿瘤。 在自组装蛋白纳米物上的表面改变剂如聚乙二醇的致密涂层增强了局部给药后粘膜组织的制剂的快速和均匀分布,增强了静脉内给药后的循环时间,并增强缺氧肿瘤核心。 选择表面改变剂的密度和分子量以允许蛋白质纳米分类与肿瘤细胞受体结合并在肿瘤细胞摄取后释放化学治疗剂。 与无载体的药剂相比,在制剂中递送的试剂具有更好的疗效。 还提供了具有增强的粘液渗透和胶体稳定性的制备蛋白质纳米型制剂的方法。

著录项

  • 公开/公告号US11090391B2

    专利类型

  • 公开/公告日2021-08-17

    原文格式PDF

  • 申请/专利权人 THE JOHNS HOPKINS UNIVERSITY;

    申请/专利号US201716333501

  • 发明设计人 XINGLU HUANG;JUNG SOO SUK;JUSTIN HANES;

    申请日2017-09-18

  • 分类号A61K38;A61K47/69;A61K47/64;A61K47/60;A61K9;A61K9/50;A61K31/704;

  • 国家 US

  • 入库时间 2022-08-24 20:38:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号